Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Product Sales $ 1,859,961 $ 163,662 $ 7,497,616 $ 1,353,720
Cost of Goods Sold 737,542 48,551 2,968,515 270,293
Gross Profit 1,122,419 115,111 4,529,101 1,083,427
Operating Expenses:        
Selling, general and administrative 1,350,639 653,872 3,782,428 1,267,266
Research and development 262,065 137,496 569,587 137,496
Total operating expenses 1,612,704 791,368 4,352,015 1,404,762
Operating income (loss) (490,285) (676,257) 177,086 (321,335)
Other income (expenses):        
Interest income (expense), net 8,156 (134,504) (597,956) (155,027)
Allocated loss on equity investment 0 0 (38,552) 0
Gain on sale of equity investment (Notes 2 and 5) 0 0 7,899,306 0
Income (Loss) before income taxes (482,129) (810,761) 7,439,884 (476,362)
Provision for income taxes 0 0 0 0
NET INCOME (LOSS) $ (482,129) $ (810,761) $ 7,439,884 $ (476,362)
Earnings (loss) per share $ (0.01) $ (0.08) $ 0.24 $ (0.05)
Weighted average number of shares - basic and diluted 33,116,675 10,010,055 30,961,675 8,841,117